Related Experiment Video
Updated: Jan 11, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Patient-Centered Real-World Evidence Framework for Oncology Product Development
Nenad Medic1, Dina Filipenko2, Monica Hadi2
1BioPharmaceuticals R&D, Patient Centered Science, AstraZeneca, Cambridge, UK.
This study introduces a patient-centered real-world evidence (PCRWE) framework for oncology. It ensures patient perspectives are integrated into oncology product development, enhancing RWE generation.
Area of Science:
- Oncology
- Real-World Evidence (RWE)
- Health Outcomes Research
Background:
- Real-world evidence (RWE) is increasingly used in oncology.
- Existing RWE guidelines lack a clear definition and framework for patient-centered RWE (PCRWE).
- There is a need to incorporate patient perspectives into oncology RWE.
Purpose of the Study:
- To propose a practical methodological framework for patient-centered RWE (PCRWE) in oncology product development.
- To define PCRWE and guide its research in the oncology field.
- To address the unmet need for integrating patient voices in RWE.
Main Methods:
- Literature review of existing RWE guidelines.
- Development of a preliminary PCRWE framework based on literature findings.
- Finalization of the framework through interviews with RWE stakeholders and oncologists.
Main Results:
- A novel definition of PCRWE was established.
- A practical, interactive visual framework for PCRWE in oncology was developed.
- The framework accommodates varying user expertise and aligns terminology.
Conclusions:
- The proposed PCRWE framework provides a structured approach for oncology product development.
- It enables stakeholders to identify patient-relevant unmet needs.
- The framework facilitates the demonstration of new oncology product value from a patient perspective.
More Related Videos
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
Clinically Relevant Drug Product Specifications: Methods of Establishment
Preclinical Development: Overview
Clinical Trials: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers